Clinical trials webinar

Mike holds a Ph. D in Neurobiology. Applying an enterprise-grade blockchain infrastructure, Triall will host a series of modular eClinical solutions that directly tailor to identified pain points that make clinical operations overly complex, lengthy, and resource-inefficient.

He became an entrepreneur in and has since combined several functions that are all related to business development and innovation in the pharmaceutical and clinical domain. Helena St. Request to talk to SKGlobal Events representative. In this presentation, Dale W. Site relationships are essential for successful clinical trials. Watch this webinar to learn why site relationships matter and best practices for fostering strong ties between sites, sponsors, CROs, and patients.

This webinar features a case study where SDC simultaneously rescued two pivotal studies by building new clinical databases in iMedNet eClinical.

Watch to learn key success factors and how to apply these methods in your clinical trials. We are committed to providing experienced teams who will take ownership of your needs and are positively engaged in your projects. Email: data sdcclinical. Barbara has more than 12 years of experience in the pharmaceutical industry.

After spending many years in early drug discovery in both large and medium-size companies, Barbara transited to clinical drug development, where she currently focuses on understanding how clinical trials need to adapt to reflect the demands of tomorrow patients and on making sure that patient and site insight are included by design in clinical trial programs.

Using her leadership skills and project management experience, Barbara wants to be part of the clinical transformation taking place in the pharmaceutical industry, with the hope that clinical trials will become a care option for all patients rather than being the last option. Kristen K. Kristen provides oversight to the Drug Development Services group and supports alliance partnerships, key customers, and proposals.

Kristen started her career practicing Internal Medicine. She was responsible for reviewing efficacy and safety for all new indications as well as post-marketing safety for over 40 drugs. What study sponsors may not realize is that, through clinical trial disclosure, they can address the call for transparency and turn compliance into a strategic advantage.

Thomas Wicks is responsible for the strategy of clinical trial disclosure and transparency solutions. He has more than 20 years of experience with performance and content management solutions, specializing in applications for life sciences such as clinical trial disclosure, structured product labeling and submissions management.

He has been on focused on trial transparency since In , he was listed in the prestigious PharmaVoice Sandi has over 23 years of professional experience in the pharmaceutical industry.

She currently manages the registration and results disclosure for all Novartis clinical trials. She played an integral part in setting up the Clinical Disclosure Office at Novartis, assisting in the development of SOPs and training.

She spearheaded an automated dashboard to track and manage disclosure deliverables which improved turnover time, data quality and resource allocation. Prior to her role in Disclosure, Sandi was a Director of Operations in Oncology Global Medical Affairs where she focused on process improvement and management in a complex global matrix.

Sandi holds a Bachelor of Science from the University of Maryland. Two thirds of clinical trial sites are unable to meet original enrolment goals, with half of sites recruiting either a single patient or failing completely. Study sponsors must therefore scrutinize their current approaches to feasibility, as recruitment is such a critical part of overall trial success. This panel discussion brings together experts from the clinical trial industry and informatics to discuss best practices in study feasibility and how the field can harness big data and predictive analytics to improve the overall site selection and patient recruitment process.

Innovative approaches to study feasibility promise to improve cycle times and the quality of clinical research, while also lowering cost and risk. Ashley lives outside of Philadelphia, PA with her husband and two daughters.